This is a U.S. news story, published by News | Emory University | Atlanta GA, that relates primarily to Day news.
For more U.S. news, you can click here:
more U.S. newsFor more Day news, you can click here:
more Day newsFor more biology news, you can click here:
more biology newsFor more news from News | Emory University | Atlanta GA, you can click here:
more news from News | Emory University | Atlanta GAOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
pediatric brain cancer. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest common childhood brain cancer news, brain cancers news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
childhood brain cancerNews | Emory University | Atlanta GA
•Science
Science
90% Informative
Brain cancer is the second -leading cause of death in children in the developed world.
Emory University and QIMR Berghofer Medical Research Institute study shows a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.
The drug CT-179 was shown to target a specific subset of tumor cells responsible for recurrence and therapy resistance in pediatric brain cancer.
Day said the next step is to undertake clinical trials. “We've been working with our collaborators, particularly in the U.S. and Australia , and we're very hopeful that the culmination of all this work has paved the way for the first in-human clinical testing of CT-179 in patients with brain cancer,” Day says. The international collaboration included institutions in Canada , Australia , the U.S. , Korea and Sweden ..
VR Score
92
Informative language
93
Neutral language
51
Article tone
formal
Language
English
Language complexity
69
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
12
Source diversity
10
Affiliate links
no affiliate links
